These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2179836)

  • 21. Transplacental measles immunity.
    Katz SL
    Pediatr Infect Dis J; 1998 Aug; 17(8):763. PubMed ID: 9726362
    [No Abstract]   [Full Text] [Related]  

  • 22. [Seroconversion following vaccination with a new measles vaccine strain].
    Just M; Wegmann A
    Ther Umsch; 1983 Mar; 40(3):261-3. PubMed ID: 6857567
    [No Abstract]   [Full Text] [Related]  

  • 23. [Studies on the persistence of immunity 15 years after revaccination with measles vaccine].
    Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):392-5. PubMed ID: 2598096
    [No Abstract]   [Full Text] [Related]  

  • 24. Sex differences in the humoral antibody response to live measles vaccine in young adults.
    Green MS; Shohat T; Lerman Y; Cohen D; Slepon R; Duvdevani P; Varsano N; Dagan R; Mendelson E
    Int J Epidemiol; 1994 Oct; 23(5):1078-81. PubMed ID: 7860159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antibodies to measles virus in blood sera of individuals who were not verified as having been infected with the virus (years 1984-1989)].
    Gut W; Litwińska B
    Przegl Epidemiol; 1991; 45(3):147-56. PubMed ID: 1819809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seroconversion following measles immunisation.
    Swami SS; Chandra S; Dudani IU
    J Commun Dis; 1987 Jun; 19(2):141-5. PubMed ID: 3454353
    [No Abstract]   [Full Text] [Related]  

  • 27. [Measurement of the in vitro immune response of live attenuated measles virus vaccine and antibody levels in 0 to 10-year-old children].
    Unalan H; Ustaçelebi S
    Mikrobiyol Bul; 1985 Oct; 19(4):218-28. PubMed ID: 3831724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psoriasis incidence research in young generation relating to vaccination against measles.
    Friedlănderová B; Novotný F
    Acta Univ Carol Med (Praha); 1986; 32(3-4):221-3. PubMed ID: 3434478
    [No Abstract]   [Full Text] [Related]  

  • 29. A long-term follow-up study on the efficacy of further attenuated live measles vaccine, Biken CAM vaccine.
    Isomura S; Morishima T; Nishikawa K; Hanada N; Rahman M; Terashima M; Kido S; Ueda S; Takahashi M
    Biken J; 1986 Mar; 29(1):19-26. PubMed ID: 3778422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The HLA antigen system and the immune response in measles vaccination].
    Kharit SM; Kapralova MA
    Tr Inst Im Pastera; 1985; 62():72-5. PubMed ID: 3843366
    [No Abstract]   [Full Text] [Related]  

  • 31. [The role of consultative offices on immunoprophylaxis in organizing epidemiologic surveillance of measles].
    Ignatov SA; Radomskaia FS; Makarova EN; Leĭko AP; Itkina EN; Komarevskaia RV
    Vrach Delo; 1990 Jan; (1):121-3. PubMed ID: 2330697
    [No Abstract]   [Full Text] [Related]  

  • 32. [Anti-measles humoral immunity in children with thymus hyperplasia].
    Gurvich EB; Lysenkova NV; Shishatskaia SN; Vaganov PD; Ozeretskovskiĭ NA
    Pediatriia; 1989; (9):31-3. PubMed ID: 2587164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Negative seroconversion and circulating interferon in children vaccinated with live measles vaccine.
    Izbický A; Drevo M; Domorázková E; Slonin D
    J Hyg Epidemiol Microbiol Immunol; 1977; 21(2):191-4. PubMed ID: 562373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Humoral immunity indices of measles in reinoculated schoolchildren].
    Miroshnikova NK; Smorodinova IP; Smorodintsev AA; Petrova VN
    Tr Inst Im Pastera; 1983; 61():145-51. PubMed ID: 6235627
    [No Abstract]   [Full Text] [Related]  

  • 35. [Induction of specific antibodies by measles vaccine. Study in normal and undernourished infants 6 to 24-months old].
    Maluf EM; Ribeiro RC; Rodriguez MA; Skraba I; de Carvalho JF
    Rev Inst Med Trop Sao Paulo; 1985; 27(6):353-60. PubMed ID: 3939164
    [No Abstract]   [Full Text] [Related]  

  • 36. The plaque-neutralization test as a measure of prior exposure to measles virus.
    Orenstein WA; Albrecht P; Herrmann KL; Bernier R; Bart KJ; Rovira EZ
    J Infect Dis; 1987 Jan; 155(1):146-9. PubMed ID: 3794399
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of maternal measles antibody titers and response to the measles vaccination at the age of 9 months in preterm infants.
    Ozturk S; Kavuncuoglu S; Ozbek S; Vural M
    Eur J Pediatr; 2007 Nov; 166(11):1181-2. PubMed ID: 17136351
    [No Abstract]   [Full Text] [Related]  

  • 38. Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months.
    Gans HA; Arvin AM; Galinus J; Logan L; DeHovitz R; Maldonado Y
    JAMA; 1998 Aug; 280(6):527-32. PubMed ID: 9707142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measles immunity in HIV-infected children.
    Walter EB; Katz SL; Bellini WJ
    Pediatr AIDS HIV Infect; 1994 Oct; 5(5):300-4. PubMed ID: 11361371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The immune response of children with an iron deficiency to vaccination with a live measles vaccine].
    Kazakova LM; Makrushin IM; Tsvetova GV; Arsent'eva TN; Shabaldin AV
    Pediatriia; 1992; (7-9):36-7. PubMed ID: 1475138
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.